unexpected benefits of tirzepatide Study sees potential obesity drug in tackling type 2 diabetes Read now: The SURPASS-EARLY trial

Many patients see significant results in the first 12-16 weeks , but ongoing support and maintenance may be needed to ensure long-term success

The data almost always reveals a gap between perception and reality

Victoza (liraglutide) : a once-daily injectable GLP-1 receptor agonist, also sold in a higher dose for weight loss under the brand name Saxenda

Studies show that 3045 minutes of resistance work three times weekly, combined with semaglutide and sufficient protein, produces superior body composition outcomes compared to medication alone or calorie restriction without exercise

The mean birth height of the neonates was 50.33 1.05 cm, with an average birth weight of 3,028.91 662.92 g

doi:10.3748/wjg.v25.i24.2973